Subretinal Fibrosis

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2018-02-26
Clinical Trial Update: Evaluating RXI-109 to Reduce the Progression of Subretinal Fibrosis in Subjects With NVAMD [Phase 1, Phase 2]
This clinical trial update describes a Phase 1/2 study evaluating RXI-109 to reduce progression of subretinal fibrosis in neovascular age-re…